XML 24 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statement of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
OPERATING ACTIVITIES      
Net income $ 6,416,000 $ 6,865,000 $ 7,180,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for loan losses 570,000 315,000 370,000
Investment securities gains, net (303,000) (323,000) (248,000)
Depreciation and amortization 1,066,000 1,013,000 1,049,000
Amortization of premium and discount on investment securities 119,000 669,000 737,000
Accretion of deferred loan fees, net (245,000) (603,000) (237,000)
Origination of loans held for sale (19,736,000) (17,889,000) (6,223,000)
Proceeds from sale of loans held for sale 20,628,000 17,549,000 6,022,000
Gains on sale of loans (419,000) (329,000) (237,000)
Earnings on bank-owned life insurance (403,000) (624,000) (276,000)
Deferred income taxes (93,000) 558,000 (154,000)
Stock-based compensation expense 29,000 18,000 10,000
(Gain) loss on other real estate owned (448,000) (48,000) 183,000
Other real estate owned writedowns (19,000) 102,000 123,000
(Increase) decrease in accrued interest receivable (39,000) (292,000) 40,000
Increase (decrease) in accrued interest payable 80,000 (49,000)
Other, net 678,000 121,000 (831,000)
Net cash provided by operating activities 7,801,000 7,182,000 7,459,000
INVESTING ACTIVITIES      
Proceeds from repayments and maturities 23,201,000 13,497,000 13,474,000
Proceeds from sale of securities 9,063,000 15,686,000 8,383,000
Purchases (1,744,000) (21,946,000) (12,287,000)
Increase in loans, net (76,199,000) (63,937,000) (36,222,000)
Proceeds from the sale of other real estate owned 1,607,000 1,762,000 832,000
Purchase of restricted stock (317,000)
Purchase of bank-owned life insurance (4,000,000)
Proceeds from death benefit 575,000
Purchase of premises and equipment (2,166,000) (507,000) (902,000)
Net cash used for investing activities (45,980,000) (59,445,000) (26,722,000)
FINANCING ACTIVITIES      
Net increase (decrease) in deposits 5,487,000 38,335,000 17,276,000
Increase in short-term borrowings, net 32,534,000 21,017,000 3,999,000
Repayment of other borrowings (502,000) (685,000) (985,000)
Common stock issued 11,210,000
Stock options exercised (6,000) (7,000) (50,000)
Proceeds from dividend reinvestment and purchase plan 519,000 651,000 590,000
Purchase of treasury stock (6,784,000)
Cash dividends (2,318,000) (2,153,000) (2,121,000)
Net cash provided by (used for) financing activities 46,924,000 50,374,000 18,709,000
Increase (decrease) in cash and cash equivalents 8,745,000 (1,889,000) (554,000)
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR 23,750,000 25,639,000 26,193,000
CASH AND CASH EQUIVALENTS AT END OF YEAR 32,495,000 23,750,000 25,639,000
SUPPLEMENTAL INFORMATION      
Interest on deposits and borrowings 4,190,000 3,740,000 4,119,000
Income taxes 1,335,000 800,000 2,260,000
Non-cash investing transactions:      
Loans to facilatate the sal of oter real estate owned 63,000
Transfers from loans to other real estate owned 720,000 638,000 1,030,000
Death benefit proceeds not yet not yet received from insurance company $ 575,000